News

Oculogica Inc. is pleased to highlight a publication this week by a team of concussion researchers on the value of the EyeBOX concussion diagnostic technology in patients with persisting post-concussive symptoms. The study, Metrics of concussion-related vision disorders among children and adolescents with persisting post-concussive symptoms using an objective eye tracking device, was published in the Journal

XcelABLE, a global provider of Functional Capacity Evaluations (FCEs) and Independent Medical Examinations (IMEs), has partnered with Oculogica, developer of the EyeBOX concussion test. EyeBOX has the most FDA clearances of any concussion test, and is the subject of multiple peer-reviewed publications. It was the first concussion test cleared by FDA for use without a

Scottsdale, AZ –06/05/2025- Royal Spine Surgery in Scottsdale, AZ is the latest clinic in Arizona to offer a new test to diagnose concussion, EyeBOX® manufactured by the Wisconsin based company, Oculogica. The test is based on eye-tracking technology and is the first FDA approved test for concussion that does not require a pre-injury baseline test.

The TRANSCENDENT Concussion Research Program, led by Ontario-based researchers, is the first and only site in Canada to offer the newest test for concussion, EyeBOX®. TRANSCENDENT is a research collaboration funded by the Ontario Brain Institute and supported by the CHEO (Children’s Hospital of Eastern Ontario) Research Institute and 360 Concussion Care, a multi-specialty concussion

Oculogica Inc., a pioneer in the development of non-invasive, objective diagnostic tools for brain injuries, is proud to announce that the U.S. Food and Drug Administration (FDA) has granted an expanded label for its groundbreaking EyeBOX® technology. The updated label permits clinicians to compare a patient with an injury against a normative population, allowing physicians

EyeBOX was recently featured in HealthCare Plus 24 Magazine in an article about Erika Jordan, DMS, EMT, CHT, Founder and Director of the Hyperbaric Healing Treatment Center with two locations – in Orlando, FL and New Smyrna Beach, FL. Erika discusses how EyeBOX has helped her provide the most advanced technology and objective data to

We’re thrilled to share that Oculogica’s CEO, Rosina Samadani, Ph.D., was featured on NPR’s Morning Marketplace podcast!  In the episode, Dr. Samadani discusses EyeBOX, the first FDA cleared tool to aid in the diagnosis of concussion without a pre-injury baseline, and how it is transforming concussion diagnosis.

Oculogica is proud to announce that Health Canada has approved the EyeBOX concussion diagnostic, an innovative device designed to assist healthcare providers in the diagnosis of concussions. This regulatory approval marks a major milestone for EyeBOX, which will now be available to healthcare professionals throughout Canada to help quickly and accurately assess mild traumatic brain

August 20, 2024, New Richmond, WI Oculogica Inc. is pleased to highlight a publication this week by a Department ofDefense based research team on the company’s EyeBOX concussion diagnostictechnology. The study, Comparative Performance of Three Eye-Tracking Devices inDetection of Mild Traumatic Brain Injury in Acute Versus Chronic Subject Populations,was published in Military Medicine on August 17,